FDA approves new GENE THERAPY for rare skin disease
(NaturalNews) On April 29, the U.S. Food and Drug Administration authorized Zevaskyn, a first-of-its-kind gene therapy for recessive dystrophic epidermolysis...
 | (NaturalNews) On April 29, the U.S. Food and Drug Administration authorized Zevaskyn, a first-of-its-kind gene therapy for recessive dystrophic epidermolysis... |
